TrialFrontiers in immunology2024

Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial.

Jianwei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.